$176 Million is the total value of First Light Asset Management, LLC's 66 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 16.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ATRC | Buy | ATRICURE INCcs | $12,698,000 | +73.7% | 636,170 | +28.1% | 7.20% | +43.9% |
| NEO | Buy | NEOGENOMICS INCcs | $11,188,000 | -13.8% | 2,683,090 | +7.7% | 6.34% | -28.6% |
| SPNC | Buy | SPECTRANETICS CORPcs | $10,798,000 | +39.1% | 312,258 | +6.9% | 6.12% | +15.2% |
| AKRXQ | Buy | AKORN INCcs | $8,423,000 | +8.8% | 232,692 | +9.0% | 4.77% | -9.9% |
| HBIO | Buy | HARVARD BIOSCIENCE INCcs | $8,010,000 | +84.1% | 1,412,719 | +32.8% | 4.54% | +52.5% |
| RTIX | Buy | RTI BIOLOGICS INCcs | $7,352,000 | +14.8% | 1,413,810 | +5.6% | 4.17% | -4.9% |
| NXTM | Buy | NXSTAGE MEDICAL INCcs | $6,691,000 | +47.2% | 373,164 | +7.8% | 3.79% | +22.0% |
| IG | Sell | IGI INCcs | $6,463,000 | -43.4% | 734,460 | -40.0% | 3.66% | -53.1% |
| ENZ | Buy | ENZO BIOCHEM INCcs | $5,390,000 | -7.9% | 1,213,901 | +6.8% | 3.05% | -23.7% |
| ARRY | Buy | ARRAY BIOPHARMA INCcs | $5,343,000 | +41.3% | 1,129,560 | +6.6% | 3.03% | +17.0% |
| LGND | Buy | LIGAND PHARMACEUTICALS INCcs | $4,361,000 | +21.5% | 81,952 | +7.3% | 2.47% | +0.7% |
| ALKS | Buy | ALKERMES PLCcs | $4,150,000 | +48.0% | 70,861 | +8.3% | 2.35% | +22.6% |
| QDEL | Buy | QUIDEL CORPcs | $4,138,000 | +15.9% | 143,092 | +7.7% | 2.34% | -4.0% |
| OMCL | Buy | OMNICELL INCcs | $3,990,000 | +31.3% | 120,485 | +8.4% | 2.26% | +8.8% |
| STRM | Buy | STREAMLINE HEALTH SOLUTIONScs | $3,913,000 | -0.1% | 903,732 | +6.8% | 2.22% | -17.3% |
| ELGX | Buy | ENDOLOGIX INCcs | $3,828,000 | +55.9% | 250,369 | +8.1% | 2.17% | +29.2% |
| VCYT | New | VERACYTE INCcs | $3,805,000 | – | 393,926 | +100.0% | 2.16% | – |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLCcs | $3,725,000 | +28.5% | 273,473 | +44.1% | 2.11% | +6.5% |
| NVDQ | Buy | NOVADAQ TECHNOLOGIES INCcs | $3,705,000 | +40.3% | 222,899 | +7.1% | 2.10% | +16.2% |
| ANGO | Buy | ANGIODYNAMICS INCcs | $3,698,000 | +286.0% | 194,512 | +178.6% | 2.10% | +220.0% |
| TECH | New | BIO TECHNE CORPcs | $3,626,000 | – | 39,243 | +100.0% | 2.06% | – |
| VNDA | New | VANDA PHARMACEUTICALS INCcs | $3,291,000 | – | 229,818 | +100.0% | 1.86% | – |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEWcs | $2,804,000 | +51.5% | 153,617 | +7.6% | 1.59% | +25.5% |
| STAA | Buy | STAAR SURGICAL COcs | $2,791,000 | -7.8% | 306,381 | +7.6% | 1.58% | -23.6% |
| FLDM | Buy | FLUIDIGM CORP DELcs | $2,719,000 | +49.0% | 80,613 | +8.2% | 1.54% | +23.5% |
| TEAR | Buy | TEARLAB CORPcs | $2,526,000 | -17.1% | 953,211 | +6.3% | 1.43% | -31.4% |
| HSTM | Buy | HEALTHSTREAM INCcs | $2,430,000 | +33.2% | 82,445 | +8.5% | 1.38% | +10.3% |
| CPHD | Buy | CEPHEIDcs | $2,423,000 | +33.4% | 44,758 | +8.4% | 1.37% | +10.5% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INCcs | $2,090,000 | +14.3% | 17,591 | +8.0% | 1.18% | -5.4% |
| ALGN | Buy | ALIGN TECHNOLOGY INCcs | $2,054,000 | +17.1% | 36,739 | +8.3% | 1.16% | -3.0% |
| LMAT | Buy | LEMAITRE VASCULAR INCcs | $2,013,000 | +20.4% | 263,146 | +8.3% | 1.14% | -0.3% |
| SLXP | New | SALIX PHARMACEUTICALS INCcs | $2,002,000 | – | 17,421 | +100.0% | 1.14% | – |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INCcs | $1,994,000 | +35.9% | 22,062 | +8.5% | 1.13% | +12.5% |
| LCI | Buy | LANNET INCcs | $1,962,000 | +0.7% | 45,765 | +7.3% | 1.11% | -16.6% |
| ISIS | Buy | ISIS PHARMACEUTICALS INCcs | $1,822,000 | +71.9% | 29,505 | +8.1% | 1.03% | +42.5% |
| STKL | Buy | SUNOPTA INCcs | $1,576,000 | +6.6% | 132,984 | +8.5% | 0.89% | -11.8% |
| BLUE | New | BLUEBIRD BIO INCcs | $1,468,000 | – | 16,008 | +100.0% | 0.83% | – |
| CYTK | Buy | CYTOKINETICS INC COMcs | $1,435,000 | +147.0% | 179,189 | +8.6% | 0.81% | +104.8% |
| SPPI | Sell | SPECTRUM PHARMACEUTICALS INCcs | $1,304,000 | -57.7% | 188,172 | -50.3% | 0.74% | -64.9% |
| SGNT | Sell | SAGENT PHARMACEUTICALS INCcs | $1,082,000 | -50.7% | 43,081 | -38.9% | 0.61% | -59.2% |
| PETX | Buy | ARATANA THERAPEUTICS INCcs | $1,035,000 | +92.0% | 58,065 | +8.2% | 0.59% | +59.1% |
| ENDP | ENDO INTL PLCcs | $589,000 | +5.6% | 8,161 | 0.0% | 0.33% | -12.6% | |
| NVS | NOVARTIS A Gadr | $562,000 | -1.6% | 6,070 | 0.0% | 0.32% | -18.7% | |
| MYL | MYLAN LABS INCcs | $551,000 | +23.8% | 9,775 | 0.0% | 0.31% | +2.6% | |
| B108PS | ACTAVIS PLCcs | $524,000 | +6.7% | 2,035 | 0.0% | 0.30% | -11.6% | |
| ANTM | New | ANTHEM INC COMcs | $515,000 | – | 4,095 | +100.0% | 0.29% | – |
| HUM | HUMANA INCcs | $508,000 | +10.2% | 3,540 | 0.0% | 0.29% | -8.6% | |
| UTHR | UNITED THERAPEUTICS CORP DELcs | $495,000 | +0.8% | 3,820 | 0.0% | 0.28% | -16.4% | |
| BMY | BRISTOL MYERS SQUIBB COcs | $489,000 | +15.3% | 8,290 | 0.0% | 0.28% | -4.5% | |
| CELG | CELGENE CORPcs | $479,000 | +18.0% | 4,280 | 0.0% | 0.27% | -2.5% | |
| AET | AETNA INC NEWcs | $463,000 | +9.7% | 5,215 | 0.0% | 0.26% | -9.3% | |
| CFN | CAREFUSION CORPcs | $459,000 | +31.1% | 7,730 | 0.0% | 0.26% | +8.8% | |
| STE | STERIS CORPcs | $411,000 | +20.2% | 6,330 | 0.0% | 0.23% | -0.4% | |
| AZN | ASTRAZENECA PLCadr | $400,000 | -1.5% | 5,680 | 0.0% | 0.23% | -18.3% | |
| JNJ | JOHNSON AND JOHNSONcs | $399,000 | -2.0% | 3,820 | 0.0% | 0.23% | -18.7% | |
| STJ | ST JUDE MED INCcs | $394,000 | +8.2% | 6,055 | 0.0% | 0.22% | -10.4% | |
| BDX | BECTON DICKINSON AND COcs | $389,000 | +22.3% | 2,795 | 0.0% | 0.22% | +0.9% | |
| LLY | LILLY ELI AND COcs | $379,000 | +6.5% | 5,495 | 0.0% | 0.22% | -11.9% | |
| MRK | MERCK N CO INC NEWcs | $375,000 | -4.3% | 6,610 | 0.0% | 0.21% | -20.5% | |
| AMGN | AMGEN INCcs | $371,000 | +13.5% | 2,330 | 0.0% | 0.21% | -6.2% | |
| CYH | COMMUNITY HEALTH SYS INC NEWcs | $331,000 | -1.8% | 6,145 | 0.0% | 0.19% | -18.6% | |
| PFE | PFIZER INCcs | $328,000 | +5.5% | 10,520 | 0.0% | 0.19% | -12.7% | |
| MYGN | MYRIAD GENETICS INCcs | $266,000 | -11.9% | 7,820 | 0.0% | 0.15% | -27.1% | |
| SNY | Sell | SANOFI-SYNTHELABOadr | $259,000 | -90.8% | 5,680 | -88.6% | 0.15% | -92.3% |
| A | AGILENT TECHNOLOGIES INCcs | $210,000 | -28.1% | 5,120 | 0.0% | 0.12% | -40.5% | |
| BIO | New | BIO RAD LABS INCcs | $202,000 | – | 1,675 | +100.0% | 0.11% | – |
| V107SC | Exit | WELLPOINT INCcs | $0 | – | -4,095 | -100.0% | -0.34% | – |
| ABCO | Exit | ADVISORY BRD COcs | $0 | – | -36,226 | -100.0% | -1.16% | – |
| TECH | Exit | TECHNE CORPcs | $0 | – | -36,566 | -100.0% | -2.34% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.